{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:27:02Z","timestamp":1793896022165,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003472","name":"Harbin Institute of Technology","doi-asserted-by":"publisher","award":["HIT.OCEF.2022029"],"award-info":[{"award-number":["HIT.OCEF.2022029"]}],"id":[{"id":"10.13039\/501100003472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202316"],"award-info":[{"award-number":["82202316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115028","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:48:25Z","timestamp":1779292105000},"page":"115028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A pH-sensitive polyprodrug nanoreactor to alleviate immunosuppression by programmed tumor-specific lactate depletion and indoleamine 2,3-dioxygenase 1 inhibition"],"prefix":"10.1016","volume":"396","author":[{"given":"Shuo","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshui","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuikun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115028_bb0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115028_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2026.115028_bb0030","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","article-title":"Cancer\u2019s molecular sweet tooth and the Warburg effect","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115028_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2026.115028_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115028_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115028_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115028_bb0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115028_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2026.115028_bb0065","article-title":"Interfering with lactate-fueled respiration for enhanced photodynamic tumor therapy by a porphyrinic MOF nanoplatform","volume":"28","author":"Chen","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0075","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115028_bb0080","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase a: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.jconrel.2026.115028_bb0085","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115028_bb0090","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1002\/anie.202002649","article-title":"Inhibition of tumor progression through the coupling of bacterial respiration with tumor metabolism","volume":"59","author":"Chen","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115028_bb0095","doi-asserted-by":"crossref","first-page":"2207951","DOI":"10.1002\/adma.202207951","article-title":"Lactate-oxidase-instructed cancer diagnosis and therapy","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0925-4005(00)00469-X","article-title":"Investigation into immobilisation of lactate oxidase to improve stability","volume":"68","author":"Lillis","year":"2000","journal-title":"Sens. Actuators B"},{"key":"10.1016\/j.jconrel.2026.115028_bb0105","first-page":"153","article-title":"Exhausted local lactate accumulation via injectable nanozyme-functionalized hydrogel microsphere for inflammation relief and tissue regeneration","volume":"12","author":"Shen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115028_bb0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s42255-020-0243-4","article-title":"Lactate: the ugly duckling of energy metabolism","volume":"2","author":"Rabinowitz","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jconrel.2026.115028_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2712","article-title":"Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy","volume":"15","author":"Cao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115028_bb0125","doi-asserted-by":"crossref","first-page":"22054","DOI":"10.1002\/anie.202001469","article-title":"Openwork@dendritic mesoporous silica nanoparticles for lactate depletion and tumor microenvironment regulation","volume":"59","author":"Tang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115028_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904639","article-title":"Intra\/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors","volume":"31","author":"Gao","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115028_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrc2639","article-title":"Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?","volume":"9","author":"L\u00f6b","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0145","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","article-title":"Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy","volume":"21","author":"Zhai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115028_bb0150","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1002\/anie.201100884","article-title":"Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells","volume":"50","author":"Zhou","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115028_bb0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41565-022-01085-5","article-title":"A transistor-like pH-sensitive nanodetergent for selective cancer therapy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0160","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1021\/ma9804951","article-title":"Living free-radical polymerization by reversible addition\u2212fragmentation chain transfer: the RAFT process","volume":"31","author":"Chiefari","year":"1998","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2026.115028_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional Enhanced Permeability and Retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115028_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901223","article-title":"Size-dependent EPR effect of polymeric nanoparticles on tumor targeting","volume":"9","author":"Kang","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0175","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899735","article-title":"Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival","volume":"37","author":"Pathria","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2026.115028_bb0180","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1158\/0008-5472.CAN-10-4633","article-title":"18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers","volume":"71","author":"Palaskas","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115028_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.103","article-title":"Tumor-derived lactic acid contributes to the paucity of intratumoral ILC2s","volume":"30","author":"Wagner","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115028_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.jconrel.2026.115028_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115028_bb0200","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.115028_bb0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0215","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc928","article-title":"New aspects of natural-killer-cell surveillance and therapy of cancer","volume":"2","author":"Smyth","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0220","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115028_bb0225","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0230","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115028_bb0235","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115028_bb0240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0245","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115028_bb0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12282-023-01522-w","article-title":"IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G","volume":"31","author":"Jing","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.actbio.2020.01.039","article-title":"Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy","volume":"106","author":"Sun","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115028_bb0265","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115028_bb0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellimm.2014.02.005","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells","volume":"289","author":"Wang","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0275","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1007\/s00432-022-04277-7","article-title":"IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma","volume":"149","author":"Struckmeier","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115028_bb0280","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115028_bb0285","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115028_bb0290","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115028_bb0295","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:59:11Z","timestamp":1793894351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":59,"alternative-id":["S0168365926004311"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pH-sensitive polyprodrug nanoreactor to alleviate immunosuppression by programmed tumor-specific lactate depletion and indoleamine 2,3-dioxygenase 1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115028"}}